CombiGene’s CEO to BioStock: “I am looking forward to meeting more potential partners”

CombiGene has a clear strategy to identify new, promising projects and academic research collaborations, but also to find a new development partner for the epilepsy project CG01. These objectives were on the agenda when CEO Peter Ekolind presented the company at NLSDays in Malmö.

Read the full interview with Peter Ekolind at biostock.se:

https://www.biostock.se/en/2024/09/combigenes-ceo-i-am-looking-forward-to-meeting-more-potential-partners/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/